Evidence map›Paper›PMID 31250824›Full record

ArticleThe Lancet. Infectious diseases2019

Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study.

Mark W Tenforde, Margaret Mokomane, Tshepo B Leeme, Nametso Tlhako, Katlego Tsholo, Tony Chebani, Anya Stephenson, Jemima Hutton, Hannah K Mitchell, Raju Kk Patel and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Recent advances in diagnostic technologies for postoperative central nervous system infections: a review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  6. Article
  7. Article
  8. Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Culture-negative cryptococcal meningitis.The Lancet. Infectious diseases · 2019
    Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Mark W TenfordeDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA USA; Botswana-UPenn Partnership, Gaborone, Botswana. Electronic address: mark.tenforde@gmail.com.
Margaret MokomaneBotswana National Health Laboratory, Gaborone, Botswana.
Tshepo B LeemeBotswana-UPenn Partnership, Gaborone, Botswana.
Nametso TlhakoBotswana-UPenn Partnership, Gaborone, Botswana.
Katlego TsholoBotswana-UPenn Partnership, Gaborone, Botswana.
Tony ChebaniBotswana Ministry of Health, Gaborone, Botswana.
Anya StephensonBotswana-UPenn Partnership, Gaborone, Botswana.
Jemima HuttonBotswana-UPenn Partnership, Gaborone, Botswana.
Hannah K MitchellBotswana-UPenn Partnership, Gaborone, Botswana.
Raju Kk PatelBotswana-UPenn Partnership, Gaborone, Botswana.
William J HurtBotswana-UPenn Partnership, Gaborone, Botswana.
Tlhagiso PilatweBotswana Ministry of Health, Gaborone, Botswana.
Tiny MasupeDepartment of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana.
Mooketsi MolefiDepartment of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana.
Brandon L GuthrieDepartment of Epidemiology, University of Washington School of Public Health, Seattle, WA USA; Department of Global Health, University of Washington, Seattle, WA USA.
Carey FarquharDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA USA; Department of Global Health, University of Washington, Seattle, WA USA.
Madisa MineBotswana National Health Laboratory, Gaborone, Botswana.
Joseph N JarvisBotswana-UPenn Partnership, Gaborone, Botswana; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Botswana Open University · BWMinistry of Health · BWUniversity of Botswana · BWUniversity of Washington · USLondon School of Hygiene & Tropical Medicine · GB

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Cryptococcal antigen screening for the prevention of cryptococcal meningitis in the HIV "treat-and-treat" era: A prospective cohort and semi-quantitative lateral flow assay validation studyF32AI140511 · NIAID · UNIVERSITY OF WASHINGTON · PI TENFORDE, MARK · 2018 to 2018
$65k
Department of Health RP-2017-08-ST2-012NIAID NIH HHS F32 AI140511NIAID NIH HHS P30 AI045008NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

backgroundCNS infections are a leading cause of HIV-related deaths in sub-Saharan Africa, but causes and outcomes are poorly defined. We aimed to determine mortality and predictors of mortality in adults evaluated for meningitis in Botswana, which has an estimated 23% HIV prevalence among adults.

methodsIn this prevalent cohort study, patient records from 2004-15 were sampled from the Botswana national meningitis survey, a nationwide audit of all cerebrospinal fluid (CSF) laboratory records from patients receiving a lumbar puncture for evaluation of meningitis. Data from all patients with culture-confirmed pneumococcal and tuberculous meningitis, and all patients with culture-negative meningitis with CSF white cell count (WCC) above 20 cells per μL were included in our analyses, in addition to a random selection of patients with culture-negative CSF and CSF WCC of up to 20 cells per μL. We used patient national identification numbers to link CSF laboratory records from the national meningitis survey to patient vital registry and HIV databases. Univariable and multivariable Cox proportional hazards models were used to evaluate clinical and laboratory predictors of mortality.

findingsWe included data from 238 patients with culture-confirmed pneumococcal meningitis, 48 with culture-confirmed tuberculous meningitis, and 2900 with culture-negative CSF (including 1691 with CSF WCC of up to 20 cells per μL and 1209 with CSF WCC above 20 cells per μL). Median age was 37 years (IQR 31-46), 1605 (50%) of 3184 patients were male, 2188 (72%) of 3023 patients with registry linkage had documentation of HIV infection, and median CD4 count was 139 cells per μL (IQR 63-271). 10-week and 1-year mortality was 47% (112 of 238) and 49% (117 of 238) for pneumococcal meningitis, 46% (22 of 48) and 56% (27 of 48) for tuberculous meningitis, and 41% (1181 of 2900) and 49% (1408 of 2900) for culture-negative patients. When the analysis of patients with culture-negative CSF was restricted to those with known HIV infection, WCC (0-20 cells per μL vs >20 cells per μL) was not predictive of mortality (average hazard ratio 0·93, 95% CI 0·80-1·09).

interpretationMortality from pneumococcal, tuberculous, and culture-negative meningitis was high in this setting of high HIV prevalence. There is an urgent need for improved access to diagnostics, to better define aetiologies and develop novel diagnostic tools and treatment algorithms.

fundingNational Institutes of Health, President's Emergency Plan for AIDS Relief, National Institute for Health Research.

Indexed as

HIV InfectionsAdultBotswanaCD4 Lymphocyte CountCohort StudiesFemaleHumansMaleMeningitis, PneumococcalPrevalenceStreptococcus pneumoniaeTuberculosis, Meningeal

Identifiers

PMID31250824
PMCPMC7645732
OpenAlexW2954258832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.